Sessions
Home
Program
Program
Speakers
Programming Committee
Site Visit
Exhibitors' Village
Start-up applications
News
Retrospectives
Practical information
Register for the Congress
Log in
fr
en
April 15, 2026
27
April 16, 2026
25
Others
11
All
Sessions
Dates
Apr 15
Apr 16
Themes
Partners
Clear all filters
April 15, 2026
27
April 16, 2026
25
Others
11
Apr 15, 2026
8:30 AM
-
9:00 AM
Accueil
Welcoming participants
Apr 15, 2026
9:00 AM
-
9:30 AM
Auditorium Descartes
Opening and Remarks
François
Bonneau
RÉGION CENTRE-VAL DE LOIRE
Président
Julien
Ettersperger
MEDICEN PARIS REGION
CEO
Fabien
Riolet
POLEPHARMA
Directeur général
Didier
Véron
CONGRÈS FRANCE BIOPRODUCTION
Président du congrès / président du G5 Santé
Apr 15, 2026
9:30 AM
-
10:00 AM
Auditorium Descartes
Round Table A - 2016–2026–2036: French Bioproduction, a History of Collaboration for Sustainable...
To mark the 10th anniversary of the France Bioproduction Congress, this roundtable discussion takes stock of a decade of major transformations in French bioproduction, marked by landmark projects (Bio-S SERVIER in Gidy, Modulus SANOFI in Neuville-sur-Saône, the expansion of the LFB Biomanufacturing site in Alès) and the advent of new technologies (AI, digitalization, real-time sensors, and automation...). How have these collaborations and innovations contributed to strengthening the sector’s autonomy? What lessons can be drawn for the next 10...
Pierre
Boyer
SERVIER FRANCE
Directeur général, Vice-président d’Initiative Pharma
Philippe
Charreau
SANOFI
Directeur Manufacturing & Supply France
Didier
Véron
CONGRÈS FRANCE BIOPRODUCTION
Président du congrès / président du G5 Santé
Apr 15, 2026
10:00 AM
-
10:30 AM
Auditorium Descartes
Round Table B - 10-Year Retrospective: Networking and Successful Collaborations Fostered by the...
In 2016, the France Bioproduction Congress was launched in the Centre-Val de Loire region. Today, it serves as the backdrop for an inspiring story: that of byoRNA, born from the meeting between Chantal Pichon, an mRNA expert at the University of Orléans–INSERM, and Thierry Ziegler, a specialist in biopharma industrialization (Merck, Sanofi, Cellectis). How does a laboratory idea turn into an innovative company? Through 20 years of research on nucleic acids and 25 years of experience in bioproduction process development and...
Thierry
Ziegler
BYORNA
Co-fondateur
Chantal
Pichon
UNIVERSITÉ ORLÉANS-INSERM
Professeure des Universités-Directrice d'unité de recherche
Apr 15, 2026
10:30 AM
-
11:00 AM
Auditorium Descartes
Round table C – From Concept to Reality: CALIPSO and the Rise of Predictive Intelligence for...
Launched in 2021 with a budget of €17.5 million (including €8 million of public funding through Bpifrance/PIA), the CALIPSO project has revolutionized bioproduction by developing: - Smart micro‑sensors for real-time process monitoring - Digital twins and integrated databases enabling advanced modeling - Automation solutions paving the way for more personalized and flexible medicine Led by a high‑level consortium (Sanofi, Capgemini, CentraleSupélec, CEA‑Leti, Ypso‑Facto, GPC Bio, BPI), the project aims to increase productivity by up to...
Patrick
Perré
CENTRALESUPELEC
Professeur, directeur de la Chaire de Biotechnologie
Maxime
Mock
CAPGEMINI
Scientific Expert Lead - Data Scientist
Eric
Calvosa
SANOFI
Project Coordinator Calipso, Global Bioprocess Expert
Béatrice
De Keukeleire
BPI FRANCE
Responsable sectorielle santé
Apr 15, 2026
11:00 AM
-
11:45 AM
Village Exposants - Espace Daniel Bourdu (niveau -2)
Break - Networking - Stands
Apr 15, 2026
11:45 AM
-
12:45 PM
Salle 1
Workshop A1 - Boost Your Bioproduction with a Comprehensive Digitalization Tool!
Delays that drag on, resource shortages, paper-based errors, lack of visibility… Bioproduction challenges are slowing down your performance. With a comprehensive digitalization tool, turn these constraints into a competitive advantage: - Immediate error reduction - Accelerated batch review - 100% digital traceability - Real-time visibility into your operations Discover how digitalizing your production records can streamline your processes, secure your data, and unlock your teams’ full potential. Join our workshop and step into the era of...
Alexandre
PLAUTE
APSALYS
Avant vente & Marketing
Apr 15, 2026
11:45 AM
-
12:45 PM
Salle 2
Workshop A2 - Mechanistic Modeling of E. coli Cultures for Bioprocess Optimization
Mechanistic models provide a quantitative framework for understanding and optimizing bioprocesses, yet their application to microbial cultures in industrial settings remains limited by the complexity of the underlying biophysical phenomena. In this work, we present a comprehensive mechanistic model of Escherichia coli cultures that integrates membrane transport phenomena, intracellular metabolic reactions, and cell division dynamics. The model predicts the influence of key process parameters, including feed composition, feeding strategy, pH,...
Lucrèce
Nicoud
YPSO FACTO
Co-CEO
Eric
Calvosa
SANOFI
Project Coordinator Calipso, Global Bioprocess Expert
Apr 15, 2026
11:45 AM
-
12:45 PM
Salle 3
Workshop A3 - Chromatography Intensification Challenges: Boosting Productivity. Scale‑up...
Introduction: Process intensification is repositioning chromatography as a cornerstone of downstream performance. Priorities now focus on optimizing and intensifying purification steps, controlling costs, and reducing facility footprint. This introduction will present the technological levers that enhance productivity, efficiency, and the environmental impact of chromatographic operations. Speaker: GUY SOUBEYROUX Then join the innovation corner of your choice: • #1 Productivity intensification through new generations of...
Jean-Philippe
Boursier
CYTIVA
AKTA Specialist
Gaëtan
Combaud
CYTIVA
Resins Specialist
Philippe
Van Vyve
CYTIVA
Downstream Hardware Specialist
Valentin
Giroux
CYTIVA
Cell Culture Specialist
Guy
Soubeyroux
CYTIVA
Senior Director – Sustainability
Apr 15, 2026
11:45 AM
-
12:45 PM
Salle 4
Workshop A4 - Optimizing Process Conditions for Scalable, Serum-Free Lentivirus Production in...
The clinical and commercial success of gene therapies depends on scalable, efficient, and cost-effective viral vector manufacturing platforms. Lentivirus (LV) production faces key challenges that impact both yield and product quality. Adherent, static culture systems (such as multi-trays and roller bottles) support efficient transfection and maintain healthy cells, resulting in high titers and good viral quality. However, scaling up with these systems involves handling large numbers of vessels, which introduces operational complexity and...
Thomas
Robert
UNIVERCELLS TECHNOLOGIES
Senior Innovation & Scientific Affairs Lead
Saci
Iken
UNIVERCELLS TECHNOLOGIES
Account Manager South Europe / North Africa
Apr 15, 2026
11:45 AM
-
12:45 PM
Salle 5
Workshop A5 - Beyond greenwashing: how to drive real sustainability through collaboration
Sustainability is not only a corporate objective—it is a responsibility shared across teams and functions. Through a structured process review exercise, participants will assess where improvements can be made. Examples of Merck’s greener solutions and initiatives will provide practical guidance for integrating sustainability into everyday decision-making.
Mehdi
Boukami
MERCK
Field Marketing Specialist - Single-Use Technologies
Apr 15, 2026
11:45 AM
-
12:45 PM
Salle 6
Workshop A6 - Lactococcus lactis: a promising and efficient platform for the bioproduction of...
Lactococcus lactis, a gram-positive bacterium considered the model lactic acid bacteria, emerged at the beginning of the 21st century as a good alternative for protein expression and characterizations. Already largely used in industry for production of fermented foods and consumed by humans for hundreds of years, this “generally recognized as safe” (GRAS) microorganism can express soluble and membrane proteins, including therapeutic proteins and bacterial and viral antigens for vaccination even at the industrial scale. L. lactis is an...
Annie
Frelet-Barrand
INSTITUT FEMTO-ST
Chercheure CNRS HDR / Equipe BIND
Apr 15, 2026
12:45 PM
-
2:15 PM
Village Exposants - Espace Daniel Bourdu (niveau -2)
Lunch cocktail reception - Networking - Stands
Apr 15, 2026
2:15 PM
-
2:35 PM
Auditorium Descartes
Conference No. 1 - Facilitating Process Intensification through Mechanistic Modelling: Application...
The manufacturing of blood-derived therapeutics remains challenging due to complex purification sequences and the need to increase the industrial productivity in order to make better use of plasma donations. Simplification of processes by the use of affinity chromatography is promising but facing reuse and scale issues to overcome. Aptamer affinity resins with its high resistance to harsh cleaning solutions will allow extensive resin use and multi-column continuous chromatography can reduce significantly size of industrial equipment. However,...
Damien
Bataille
LFB Biotechnologies
Responsable département procédés
Edouard
Nicoud
YPSO FACTO
Co-CEO
Apr 15, 2026
2:35 PM
-
2:55 PM
Auditorium Descartes
Conference No. 2 - CALIPSO Sensors & CEA: A Public–Private Partnership Strengthening Our...
The Calipso project between CEA-Leti and GPC is nearing completion. It focused on developing innovative sensors and systems for the in-line and at-line measurement of critical USP (pH, conductivity, dissolved gas temperature) and DSP (endotoxins, HCP) parameters. This presentation will first address the main results obtained during this project, the level of maturity and innovation provided by the sensors, and the field results. It will then discuss the partnership between the the newly created industrial start-up Calipso Sensors and...
Nadège
Nief
CEA
Adjointe à la division Santé du CEA-Leti
Cyril
Van Robais
CALIPSO SENSORS SAS
Directeur Opérationnel
Zsolt
Popsé
GLOBAL PROCESS CONCEPT SAS & CALIPSO SENSORS SAS
CEO
Apr 15, 2026
2:55 PM
-
3:15 PM
Auditorium Descartes
Conference No. 3 - Continuous biomanufacturing beyond stirred tank constraints
Description coming soon
Román
Ortega Bianchi
STÄMM
Head of BD
Apr 15, 2026
3:15 PM
-
3:45 PM
Auditorium Descartes
Round Table No. 2 - Q&A - With the Session 2 speakers
Damien
Bataille
LFB Biotechnologies
Responsable département procédés
Nadège
Nief
CEA
Adjointe à la division Santé du CEA-Leti
Cyril
Van Robais
CALIPSO SENSORS SAS
Directeur Opérationnel
Zsolt
Popsé
GLOBAL PROCESS CONCEPT SAS & CALIPSO SENSORS SAS
CEO
Román
Ortega Bianchi
STÄMM
Head of BD
Edouard
Nicoud
YPSO FACTO
Co-CEO
Apr 15, 2026
3:45 PM
-
4:30 PM
Village Exposants - Espace Daniel Bourdu (niveau -2)
Break - Networking - Stands
Apr 15, 2026
4:30 PM
-
5:30 PM
Salle 1
Workshop B1 - Building Tomorrow’s Bioproduction Together Through Precision Fermentation
Join a dynamic, hands‑on session to explore how precision fermentation can scale and transform the bioproduction of biotherapies. Together, we’ll identify the key barriers, uncover the most promising opportunities, and co‑create actionable challenges that will feed into upcoming cross‑regional hackathons. A fast‑paced format combining group work, exchanges, and matchmaking — designed to spark ideas and shape tomorrow’s industrial solutions.
Maëlle
Ferrier
MEDICEN PARIS REGION
Responsable filière Biotech & Pharma
Apr 15, 2026
4:30 PM
-
5:30 PM
Salle 2
Workshop B2 - Game On !! Exploring Upstream workflows with Next-Gen Filtration & Separation...
The first part of this interactive workshop will be a game exploring the flexibility of our Upstream workflow solutions, from the bioreactor culture stage through to the harvest stage in single-use bags, providing a complete solution regardless of the selected clarification strategy. The second part will allow participants to put the identified solution into practice using our brand new Single-Use Configurator.
Catherine
BINEAU
THERMO FISHER SCIENTIFIC
Ingénieur Senior - Applications en Bioprocédés
Marion
Gros
THERMO FISHER SCIENTIFIC
Ingénieur - Applications en Bioprocédés
Arnaud
REHEL
THERMO FISHER SCIENTIFIC
Responsable Single-use France, Wallonie & Afrique
Apr 15, 2026
4:30 PM
-
5:30 PM
Salle 3
Workshop B3 - The 10 g/L Wall Has Fallen in USP: What Is the Impact on Industrialization and DSP?
Since 2025, double digit titers of proteins of interest (primarily mAbs) have been seen in USP bioreactors from PD to pilot scale. However, these very high titers will impact large-scale purification streams (“DSP”) and drive them to evolve. Process intensification will thus move from scientific buzz to an indispensable reality, which is part of a profound transformation of the industry that began long ago. This workshop aims to visualize the impacts of double digit titers on industrial production strategies, taking into account annual...
Apr 15, 2026
4:30 PM
-
5:30 PM
Salle 4
Workshop B4 - Case Study in a Collaborative 3D Serious Game: Immerse Yourself in a Regulatory...
3D serious game. In this workshop we will collectively participate in a rela lerning element of an innovative digital training module. Come and strengthen your knowledge in biopharmaceutical data integrity through a practical scenario.
Benoit
Consigny
IMMERSCIO.BIO
Chargé de Développement Commercial
Geoffroy
Malherbe
IMMERSCIO.BIO
Sales Director
Apr 15, 2026
4:30 PM
-
5:30 PM
Salle 5
Workshop B5 - Accelerating Bioproduction Release: Overcoming QC Bottlenecks with Rapid Testing
Reducing release timelines is not only about speeding up manufacturing, but also about removing QC bottlenecks while maintaining regulatory compliance. Rapid testing can be a powerful lever, if used wisely. In this workshop, we will walk through where rapid methods can fit across the CHO manufacturing process, from cell line characterization through bulk harvest testing. We will review case studies using rapid molecular and NGS-based technologies to discuss the considerations and impact of these approaches compared to more traditional...
Sandra
de Barros
MERCK
Senior Technical Sales Specialist
Apr 15, 2026
4:30 PM
-
5:30 PM
Salle 6
Workshop B6
Description coming soon
Apr 15, 2026
5:30 PM
-
6:00 PM
Auditorium Descartes
Conference No. 4 - Premium - Innovation, bioproduction, and merket authorization: Fabentech at the...
As biological threats — whether natural or intentional — continue to rise, the ability to rapidly develop, manufacture and deploy medical countermeasures has become a critical strategic priority for healthcare systems and European sovereignty. Fabentech is at the forefront of this transformation, developing innovative immunotherapies based on polyclonal antibodies capable of effectively targeting complex and evolving pathogens. This approach, combined with a modular technology platform and integrated biomanufacturing capabilities,...
Sébastien
Iva
FABENTECH
CEO
Apr 15, 2026
6:10 PM
-
6:20 PM
Auditorium Descartes
Closing speech on the first day
Apr 15, 2026
7:30 PM
-
10:30 PM
Brasserie L'Univers
Networking Cocktail Evening
Brasserie de l'Univers, 8 Jean Jaurès Square, 37000 Tours